Significance of isolated reactive treponemal chemiluminescence immunoassay results

Journal of Infectious Diseases

Volumn 207, Issue 9, 2013, Pages 1416-1423

  Hunter, Michael G ^a   Robertson, Peter W ^b   Post, Jeffrey J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Chemiluminescence immunoassay; discordant; seroreversion; syphilis; Treponema pallidum

Indexed keywords

ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; FEMALE; FLUORESCENT TREPONEMA ANTIBODY TEST; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; REAGIN TEST; SEROLOGY; SYPHILIS; TREPONEMA PALLIDUM; TREPONEMA PALLIDUM HEMAGGLUTINATION TEST;

ADULT; AGED; FEMALE; HUMANS; INFANT, NEWBORN; LUMINESCENCE; MALE; MIDDLE AGED; PREGNANCY; SYPHILIS; SYPHILIS SERODIAGNOSIS; TREPONEMA PALLIDUM; YOUNG ADULT;

EID: 84867630283     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis459     Document Type: Article

References (23)

1. Fenton KA, Breban R, Vardavas R, et al. Infectious syphilis in highincome settings in the 21st century. Lancet Infect Dis 2008; 8:244-53. (Pubitemid 351391990)
2. The Kirby Institute: HIV, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2011. Sydney, Australia: The Kirby Institute, the University of New South Wales, 2011.
3. Young H, Moyes A, Seagar L, McMillan A. Novel recombinantantigen enzyme immunoassay for serological diagnosis of syphilis. J Clin Microbiol 1998; 36:913-7. (Pubitemid 28146268)
4. Radolf JD, Lernhardt EB, Fehniger TE, Lovett MA. Serodiagnosis of syphilis by enzyme-linked immunosorbent assay with purified recombinant Treponema pallidum antigen 4D. J Infect Dis 1986; 153:1023-7. (Pubitemid 16086768)
5. Young H, Pryde J, Duncan L, Dave J. The Architect Syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilis. Sex Transm Infect 2009; 85:19-23.
6. Sena AC, White BL, Sparling PF. Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis 2010; 51:700-8.
7. Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204:1297-304.
8. Discordant results from reverse sequence syphilis screening-five laboratories, United States, 2006-2010. MMWR Morb Mortal Wkly Rep 2011; 60:133-7.
9. Syphilis testing algorithms using treponemal tests for initial screening-four laboratories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep 2008; 57:872-5.
10. Woznicova V, Valisova Z. Performance of CAPTIA SelectSyph-G enzyme-linked immunosorbent assay in syphilis testing of a high-risk population: analysis of discordant results. J Clin Microbiol 2007; 45:1794-7. (Pubitemid 46933909)
11. Ooi C, Robertson P, Donovan B. Investigation of isolated positive syphilis enzyme immunoassay (ICE Murex) results. Int J STD AIDS 2002; 13:761-4. (Pubitemid 35222010)
12. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004; 4:456-66. (Pubitemid 38844130)
13. Tsang RS, Martin IE, Lau A, Sawatzky P. Serological diagnosis of syphilis: comparison of the Trep-Chek IgG enzyme immunoassay with other screening and confirmatory tests. FEMS Immunol Med Microbiol 2007; 51:118-24. (Pubitemid 47387490)
14. Anderson J, Mindel A, Tovey SJ, Williams P. Primary and secondary syphilis, 20 years' experience. 3: Diagnosis, treatment, and follow up. Genitourin Med 1989; 65:239-43. (Pubitemid 19240553)
15. Hunter EF, Russell H, Farshy CE, Sampson JS, Larsen SA. Evaluation of sera from patients with Lyme disease in the fluorescent treponemal antibody-absorption test for syphilis. Sex Transm Dis 1986; 13:232-6. (Pubitemid 17111807)
16. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995; 8: 1-21.
17. Goldman JN, Lantz MA. FTA-ABS and VDRL slide test reactivity in a population of nuns. JAMA 1971; 217:53-5.
18. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
19. Mishra S, Boily MC, Ng V, et al. The laboratory impact of changing syphilis screening from the rapid-plasma reagin to a treponemal enzyme immunoassay: a case-study from the Greater Toronto Area. Sex Transm Dis 2011; 38:190-6.
20. Hoover KW, Radolf JD. Serodiagnosis of syphilis in the recombinant era: reversal of fortune. J Infect Dis 2011; 204:1295-6.
21. Janier M, Chastang C, Spindler E, et al. A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis. Dermatology 1999; 198:362-9. (Pubitemid 29335729)
22. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med 1991; 114:1005-9.
23. Maple PAC, Ratcliffe D, Smit E. Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassays. Clin Vaccine Immunol 2010; 17:1718-22.